Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: Development and validation of a simple risk score

Archives of Internal Medicine

Volumn 169, Issue 17, 2009, Pages 1595-1602

  Tabak, Ying P ^a   Sun, Xiaowu ^a   Johannes, Richard S ^a,b   Gupta, Vikas ^a   Shorr, Andrew F ^c  

^a West River Pharm   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BOOTSTRAPPING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXTERNAL VALIDITY; FEMALE; HIGH RISK PATIENT; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL; VALIDATION STUDY;

AGE FACTORS; AGED; BLOOD UREA NITROGEN; FEMALE; HEART RATE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; VENTILATORS, MECHANICAL;

EID: 70349762056     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.270     Document Type: Article

References (32)

1. American Lung Association, Epidemiology & Statistics Unit, Research and Program Services. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. http://www.lungusa.org/atf/cf/%7B7a8d42c2-fcca-4604 -8ade-7f5d5e762256%7D/COPD-DEC07.PDF. Accessed May 19, 2008.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
3. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000; 117(2)(suppl):5S-9S.
4. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5, pt 1):1418-1422. (Pubitemid 28242071)
5. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and meta-analysis. Chest. 2008;133(3):756-766.
6. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555.
7. Kerstjens HAM. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med. 2004;170(3):212-213.
8. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250. (Pubitemid 27044625)
9. Iezzoni LI, Moskowitz MA. A clinical assessment of MedisGroups. JAMA. 1988; 260(21):3159-3163.
10. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862. (Pubitemid 43062645)
11. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcare-associated bloodstream infection: a distinct entity? insights from a large US database. Crit Care Med. 2006;34(10):2588-2595. (Pubitemid 44413057)
12. Silber JH, Rosenbaum PR, Schwartz JS, Ross RN, Williams SV. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery. JAMA. 1995;274(4):317-323.
13. Tabak YP, Johannes RS, Silber JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care. 2007;45(8):789-805.
14. R Development Core Team. R: A language and environment for statistical computing, reference index version 2.9.0. Vienna, Austria: R Foundation for Statistical Computing. 2009. http://www.r-project.org/. Accessed April 25, 2009.
15. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the RPART routines. http://ndc.mayo.edu/mayo/research/biostat/upload/61.pdf. Accessed May 22, 2008.
16. Therneau TM, Atkinson EJ. rpart: Recursive partitioning. http://cran.r-project .org/web/packages/rpart/index.html. Accessed May 22, 2008.
17. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont, CA: Wadsworth International; 1984.
18. Goldman L, Cook EF, Johnson PA, Brand DA, Rouan GW, Lee TH. Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med. 1996;334(23):1498-1504. (Pubitemid 26166892)
19. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572-580.
20. Aujesky D, Obrosky DS, Stone RA, et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med. 2006;166(2):169-175. (Pubitemid 43144939)
21. Takahashi O, Cook EF, Nakamura T, Saito J, Ikawa F, Fukui T. Risk stratification for in-hospital mortality in spontaneous intracerebral haemorrhage: a classification and regression tree analysis. QJM. 2006;99(11):743-750. (Pubitemid 44688408)
22. Fresco C, Carinci F, Maggioni AP, et al; GISSI investigators. Very early assessment of risk for in-hospital death among 11,483 patients with acute myocardial infarction. Am Heart J. 1999;138(6, pt 1):1058-1064.
23. Efron B, Tibshirani R. An Introduction to the Bootstrap. London, England: Chapman & Hall; 1993.
24. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894-903. (Pubitemid 46768129)
25. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
26. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382. (Pubitemid 36560938)
27. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012. (Pubitemid 38269277)
28. Morrow DA, Cannon CP, Jesse RL, et al; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356-e375. (Pubitemid 46648624)
29. Tang WH, Francis GS, Morrow DA, et al; National Academy of Clinical Biochemistry Laboratory Medicine. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation. 2007;116(5):e99-e109.
30. Stolz D, Breidthardt T, Christ-Crain M, et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest. 2008;133(5): 1088-1094. (Pubitemid 351685510)
31. Mapel DW, McMillan GP, Frost FJ, et al. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med. 2005;99(10): 1325-1333. (Pubitemid 41245321)
32. Tabak YP, Johannes RS, Silber JH, Kurtz SG. Should do-not-resuscitate status be included as a mortality risk adjustor? the impact of DNR variations on performance reporting. Med Care. 2005;43(7):658-666.